Editor’s Highlight: Nlrp3 Is Required for Inflammatory Changes and Nigral Cell Loss Resulting From Chronic Intragastric Rotenone Exposure in Mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Toxicological Sciences

• Publication date

  2017-09-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/toxsci/kfx117PMID 28903492PMCID PMC5837210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of Parkinson's disease

  2018cited by this paper
• The role of mitochondria in NLRP3 inflammasome activation.

  2018cited by this paper
• Caspase-1 Deficiency Alleviates Dopaminergic Neuronal Death via Inhibiting Caspase-7/AIF Pathway in MPTP/p Mouse Model of Parkinson’s Disease

  2017influential reference
• Neutrophils as protagonists and targets in chronic inflammation

  2017cited by this paper
• Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes

  2017cited by this paper
• Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome

  2016cited by this paper
• Recent advances in understanding neutrophils

  2016cited by this paper
• MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer's disease dementia phenotypes

  2016cited by this paper
• Converging mediators from immune and trophic pathways to identify Parkinson disease dementia

  2016cited by this paper
• Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease*

  2016cited by this paper
• NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice.

  2016cited by this paper
• An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions.

  2015cited by this paper
• Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome.

  2015influential reference
• NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes

  2015influential reference
• Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation*

  2015cited by this paper
• Pesticide‐induced Mitochondrial Dysfunction Augments NLRP3 Inflammasome Signaling Pathway in Primary Microglia

  2015influential reference
• Microglial brain region-dependent diversity and selective regional sensitivities to ageing

  2015cited by this paper
• Gene-gene and gene-environment interaction on the risk of Parkinson's disease.

  2014cited by this paper
• An anti-inflammatory NOD-like receptor is required for microglia development.

  2013cited by this paper
• Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models.

  2013cited by this paper
• Neutrophil recruitment and function in health and inflammation

  2013cited by this paper
• [Epidemiology of Parkinson's disease].

  2013cited by this paper
• The interplay between environmental and genetic factors in Parkinson's disease susceptibility: the evidence for pesticides.

  2013cited by this paper
• Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies

  2013cited by this paper
• NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice

  2012cited by this paper
• Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice

  2012cited by this paper
• Genetics of Parkinson's disease.

  2012cited by this paper
• Classic and New Animal Models of Parkinson's Disease

  2012cited by this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011cited by this paper
• Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 mice.

  2011influential reference
• The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

  2011cited by this paper
• Abnormal peripheral chemokine profile in Huntington’s disease

  2011cited by this paper
• Rotenone, Paraquat, and Parkinson’s Disease

  2011cited by this paper
• A guide to neurotoxic animal models of Parkinson's disease.

  2011cited by this paper
• A role for mitochondria in NLRP3 inflammasome activation

  2011cited by this paper
• The inflammasomes.

  2010cited by this paper
• Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice

  2010influential reference
• Lessons from the rotenone model of Parkinson's disease.

  2010cited by this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• Molecular dissection of reactive astrogliosis and glial scar formation.

  2009influential reference
• Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology.

  2009cited by this paper
• A highly reproducible rotenone model of Parkinson's disease.

  2009cited by this paper
• Genetic susceptibility in Parkinson's disease.

  2009cited by this paper
• Astrocytes: biology and pathology

  2009cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Neutrophil mobilization and clearance in the bone marrow

  2008cited by this paper
• α‐Chemokines Regulate Proliferation, Neurogenesis, and Dopaminergic Differentiation of Ventral Midbrain Precursors and Neurospheres

  2008cited by this paper
• Gene-environment interactions in Parkinson's disease.

  2007cited by this paper
• Chronic Interleukin-1β Expression in Mouse Brain Leads to Leukocyte Infiltration and Neutrophil-Independent Blood–Brain Barrier Permeability without Overt Neurodegeneration

  2007influential reference
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver.

  2005cited by this paper
• The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia1

  2005cited by this paper
• Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

  2004cited by this paper
• The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

  2004cited by this paper
• Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration

  2003cited by this paper
• Selective microglial activation in the rat rotenone model of Parkinson's disease.

  2003influential reference
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.

  1999cited by this paper
• Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model.

  1996cited by this paper
• Neutrophil function, nitric oxide, and blood oxidative stress in Parkinson's disease

  1996cited by this paper
• Microglia: a sensor for pathological events in the CNS.

  1996cited by this paper
• Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system.

  1991influential reference
• The role of environmental toxins in the etiology of Parkinson's disease.

  1989cited by this paper
• Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

  1988cited by this paper

• Mitophagy–NLRP3 Inflammasome Crosstalk in Parkinson’s Disease: Pathogenic Mechanisms and Emerging Therapeutic Strategies

  2026cites this paper
• Coronin1A Regulates the Trafficking of Alpha Synuclein in Microglia

  2025cites this paper
• Complex I superoxide anion production is necessary and sufficient for complex I inhibitor-induced dopaminergic neurodegeneration in Caenorhabditis elegans

  2025cites this paper
• New Insights on the Potential Role of Pyroptosis in Parkinson’s Neuropathology and Therapeutic Targeting of NLRP3 Inflammasome with Recent Advances in Nanoparticle-Based miRNA Therapeutics

  2025cites this paper
• Computational Identification and Functional Analysis of Potentially Pathogenic nsSNPs in the NLRP3 Gene Linked to Alzheimer’s Disease

  2024cites this paper
• Investigation of pesticide residues based on integrated multi-strategy: occurrence, fate and dietary risk assessment

  2024cites this paper
• Innate immune activation in neurodegenerative diseases.

  2024cites this paper
• Molecular crosstalk between circadian clock and NLRP3 inflammasome signaling in Parkinson's disease

  2024cites this paper
• The gut-brain axis: Unveiling the impact of xenobiotics on neurological health and disorders.

  2024cites this paper
• Neuroinflammation in Age-Related Neurodegenerative Diseases: Role of Mitochondrial Oxidative Stress

  2024cites this paper
• The genetic advantage of healthy centenarians: unraveling the central role of NLRP3 in exceptional healthspan

  2024cites this paper
• HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson's disease.

  2023cites this paper
• Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson's disease.

  2023cites this paper
• Role of NLRP3 Inflammasomes in Neurodegenerative Diseases

  2023cites this paper
• Proof-of-Principle Study of Inflammasome Signaling Proteins as Diagnostic Biomarkers of the Inflammatory Response in Parkinson’s Disease

  2023cites this paper
• Nardostachys jatamansi and levodopa combination alleviates Parkinson’s disease symptoms in rats through activation of Nrf2 and inhibition of NLRP3 signaling pathways

  2023influential citation
• Response to Comment on “Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice”

  2023cites this paper
• Rotenone induces regionally distinct α-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl/6 mice.

  2022cites this paper
• Inflammasome Activation in Parkinson’s Disease

  2022cites this paper
• NLRP3 inflammasome in neurodegenerative disease.

  2022cites this paper
• Parkinson's disease: connecting mitochondria to inflammasomes.

  2022cites this paper
• BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease

  2022cites this paper
• The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease

  2022cites this paper
• Astrocyte inflammatory signaling mediates α-synuclein aggregation and dopaminergic neuronal loss following viral encephalitis.

  2021cites this paper
• Role of Microgliosis and NLRP3 Inflammasome in Parkinson’s Disease Pathogenesis and Therapy

  2021cites this paper
• Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients

  2021cites this paper
• A mechanistic view on the neurotoxic effects of air pollution on central nervous system: risk for autism and neurodegenerative diseases

  2021cites this paper
• Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview

  2021cites this paper
• α‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia

  2021cites this paper
• Periphery and brain, innate and adaptive immunity in Parkinson’s disease

  2021cites this paper
• Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies

  2021cites this paper
• Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

  2021cites this paper
• Papaverine Exerts Neuroprotective Effect by Inhibiting NLRP3 Inflammasome Activation in an MPTP-Induced Microglial Priming Mouse Model Challenged with LPS

  2021cites this paper
• Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease

  2021cites this paper
• Using Rotenone to Model Parkinson's Disease in Mice: A Review of the Role of Pharmacokinetics.

  2021cites this paper
• Mechanism of Gene-Environment Interactions Driving Glial Activation in Parkinson’s Diseases

  2021cites this paper
• Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation

  2021cites this paper
• Environmental neurotoxicants and inflammasome activation in Parkinson's disease - a focus on the gut-brain axis.

  2021cites this paper
• Inflammasome activation in neurodegenerative diseases.

  2021cites this paper
• Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases

  2021cites this paper
• Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation

  2021cites this paper
• Dopamine Signaling Modulates Microglial NLRP3 In�ammasome Activation: Implications for Parkinson’s Disease

  2021cites this paper
• Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson’s Disease

  2020cites this paper
• Relação entre a exposição ao pesticida Rotenona e o desenvolvimento de sintomas motores e não-motores da doença de Parkinson

  2020cites this paper
• 2,5-hexanedione induces NLRP3 inflammasome activation and neurotoxicity through NADPH oxidase-dependent pathway.

  2020cites this paper
• NLRP3 inflammasome mediates 2,5-hexanedione-induced neurotoxicity through regulation of macrophage infiltration in rats.

  2020cites this paper
• NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin.

  2020cites this paper
• The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases.

  2020cites this paper
• Slc6a3-dependent expression of a CAPS-associated Nlrp3 allele results in progressive behavioral abnormalities and neuroinflammation in aging mice

  2020cites this paper
• Mechanistic Studies of Idiosyncratic DILI: Clinical Implications

  2019cites this paper
• NLRP3 inflammasome pathway is involved in olfactory bulb pathological alteration induced by MPTP

  2019cites this paper
• The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.

  2019cites this paper
• miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease

  2019cites this paper
• Submicron Crystals of the Parkinson’s Disease Substantia nigra: Calcium Oxalate, Titanium Dioxide and Iron Oxide

  2019cites this paper
• Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

  2019cites this paper
• NLRP3 expression in mesencephalic neurons and characterization of a rare NLRP3 polymorphism associated with decreased risk of Parkinson’s disease

  2018influential citation
• The NLRP3 inflammasome: Role in metabolic disorders and regulation by metabolic pathways.

  2018cites this paper
• Inflammasomes: An Emerging Mechanism Translating Environmental Toxicant Exposure Into Neuroinflammation in Parkinson's Disease.

  2018cites this paper